Showing results (81-90 of 199) with videos related to

Sort By:
Pageof 20
Cancers|June 13, 2025
Deep-Learning-Based Prediction of t(11;14) in Multiple Myeloma H&E-Stained SamplesNadav Kerner, Dov Hershkovitz, Svetlana Trestman, et al.
British Journal of Haematology|August 29, 2025
Next-generation morphology, a novel multilayer morphometric digital analysis, reveals both the basic topology and new trends of myelodysplasia of peripheral blood specimensBen-Zion Katz, Yakir Moshe, Dan Bensity, et al.
International Journal of Molecular Sciences|March 29, 2023
Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease SeverityAnat Aharon, Ayelet Dangot, Fadi Kinaani, et al.
Annals of Hematology|November 28, 2017
Toxicity and efficacy of autologous hematopoietic cell transplantation in elderly patients with aggressive lymphoma: a historical prospective studyMarina Davidov, Chava Perry, Yair Herishanu, et al.
Leukemia & Lymphoma|April 16, 2026
Can Belantamab mafodotin cause macro LDH?Leehe Hakakian, Tamir Shragai, Svetlana Trestman, et al.
Hematological Oncology|July 8, 2020
Kinetics of pre-myelodysplastic syndromes blood values correlate with disease risk and survivalErel Joffe, Uri Greenbaum, Gili Man-El, et al.
British Journal of Haematology|January 25, 2022
BNT162b2 mRNA COVID-19 vaccine booster induces seroconversion in patients with B-cell non-Hodgkin lymphoma who failed to respond to two prior vaccine dosesIrit Avivi, Efrat Luttwak, Esther Saiag, et al.
Haematologica|April 23, 2010
A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphomaEldad J Dann, Rachel Bar-Shalom, Ada Tamir, et al.
Leukemia & Lymphoma|January 5, 2016
Primary failure of bortezomib in newly diagnosed multiple myeloma--understanding the magnitude, predictors, and significanceYael C Cohen, Erel Joffe, Noam Benyamini, et al.
Hematological Oncology|September 20, 2016
Serum free immunoglobulin light chain fingerprint identifies a subset of newly diagnosed multiple myeloma patients with worse outcomeIrit Avivi, Yael C Cohen, Erel Joffe, et al.
Pageof 20